Home › Lung Diseases › Missouri › Kansas City
Lung Diseases clinical trials in Kansas City, MO
4 studies for Lung Diseases are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Kansas City
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- The University of Kansas Cancer Center - Westwood, Westwood · 5 mi away
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
RecruitingPhase 1/2
- The University of Kansas Cancer Center, Westwood · 5 mi away
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- University of Kansas Cancer Center-Westwood, Westwood · 5 mi away
About Lung Diseases
Lung diseases are disorders or infections that affect the lungs and cause breathing problems. Some can lead to respiratory failure. Find out more about prevention, living with lung diseases, and treatment.
More about Lung Diseases on MedlinePlus
Lung Diseases trials in other cities
- Houston, TX15 studies
- Boston, MA14 studies
- Durham, NC13 studies
- New York City, NY12 studies
- Pittsburgh, PA11 studies
- Miami, FL10 studies
- Dallas, TX10 studies
- Columbus, OH10 studies
- Nashville, TN10 studies
- Los Angeles, CA10 studies
- Ann Arbor, MI10 studies
- Washington, DC10 studies
Other studies in Kansas City
- Breast Cancer34 studies
- Non-Small Cell Lung Cancer31 studies
- Heart Failure25 studies
- Cancer (all types)21 studies
- Lung Cancer19 studies
- Colorectal Cancer16 studies
- Metastatic Cancer15 studies
- Acute Myeloid Leukemia15 studies
- Prostate Cancer14 studies
- Ovarian Cancer11 studies
- Obesity11 studies
- Type 2 Diabetes11 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.